Skip to main content
NAII
NASDAQ Life Sciences

CFO Resigns Amidst Company's Financial Challenges

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
8
Price
$2.72
Mkt Cap
$16.801M
52W Low
$2.33
52W High
$4.96
Market data snapshot near publication time

summarizeSummary

Natural Alternatives International announced the resignation of its Chief Financial Officer, Michael E. Fortin, effective May 15, 2026, citing a new opportunity with increased responsibilities.


check_boxKey Events

  • Chief Financial Officer Resigns

    Michael E. Fortin has resigned from his position as Chief Financial Officer, effective May 15, 2026.

  • Reason for Departure

    Mr. Fortin accepted a CFO role at another company, citing increased responsibilities and opportunities for professional growth.

  • Interim Financial Leadership

    President Kenneth E. Wolf, who previously served as the company's CFO, will act as the Principal Financial and Principal Accounting Officer during the search for a permanent replacement.

  • Context of Financial Distress

    This executive departure occurs while the company is facing continued net losses, increased cash used in operations, and repeated debt covenant violations, as previously reported in its last 10-Q.


auto_awesomeAnalysis

The departure of Chief Financial Officer Michael E. Fortin is a significant negative development for Natural Alternatives International, especially given the company's recent disclosures of continued net losses, increased cash burn, and repeated debt covenant violations. While the company states Mr. Fortin is leaving for a role with increased responsibilities, his exit from a financially struggling micro-cap company could signal a lack of confidence in its near-term prospects. The interim appointment of the President, a former CFO, provides some stability but underscores the immediate need to find a permanent financial leader during a critical period. Investors should monitor the search for a new CFO and any further updates on the company's financial health.

At the time of this filing, NAII was trading at $2.72 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16.8M. The 52-week trading range was $2.33 to $4.96. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed NAII - Latest Insights

NAII
May 01, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
NAII
Mar 20, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
NAII
Feb 13, 2026, 4:17 PM EST
Filing Type: 10-Q
Importance Score:
9